~~<i id='803DA0C919'><strike id='803DA0C919'><tt id='803DA0C919'><pre id='803DA0C919'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：comprehensive 2025-09-30 19:44:34 Page View：552

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare wants to send $9 billion to 340B hospitals
Next article： How one medical school became remarkably diverse

explore

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

7:21NationalSecurityCouncilspokesmanJohnKirbyspeaksduringthedailybriefingattheWhiteHouseinWashington

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Presidential fundraising highlights so far: Trump brings in more than DeSantis

12:29Republicanpresidentialcandidate,formerPresidentDonaldTrumpstandsonstageafterbeingintroducedduri

WSS

hotspot

hotspot

knowledge

explore

Presidential fundraising highlights so far: Trump brings in more than DeSantis